| Announce Date | 01/08/2026 |
| EPS Normalized Actual | $1.14 (Beat by $0.3) |
| EPS GAAP Actual | $1.14 (Beat by $0.3) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 02/28/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.07 |
| EPS GAAP Estimate | $1.07 |
| Revenue Estimate | $0.8774B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Aug 2028 | 5.6 | 10.21 | 5.20612 | 5.88296 | 1 |
| Aug 2027 | 4.7 | 12.17 | 4.68002 | 4.71998 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.18 | 0.03 | 0B | NAN% | -809.43M |
| FQ3 2025 (Aug 2025) | 1.19 | -0.0033300000000001 | 0.7558B | 100% | -184.05M |
| FQ2 2025 (May 2025) | 1.92 | 1.92 | 0.8427B | 2.85% | 842.7M |
| FQ1 2025 (Feb 2025) | 1.66 | 1.66 | 0.7621B | -12.98% | 762.1M |
| FQ4 2024 (Nov 2024) | 3.9 | 3.9 | 0B | -INF% | 0M |
| FQ3 2024 (Aug 2024) | 0 | 0 | 0B | -INF% | 0M |
| FQ2 2024 (May 2024) | 1.09 | 1.09 | 0.8187B | 100% | 818.7M |
| FQ1 2024 (Feb 2024) | 1.07 | 1.07 | 0.861B | 100% | 861M |
FQ4 Announce Date
02/28/2026 (Pre-Market)
Consensus EPS Estimates
1.07
Consensus Revenue Estimates
0.8774B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Nov 2026) | 0.885 | -33.33 | 0.77769 | 0.9766 | 1 |
| FQ3 2026 (Aug 2026) | 1.3 | 8.46 | 1.28121 | 1.32167 | 2 |
| FQ2 2026 (May 2026) | 1.3 | -47.69 | 1.28121 | 1.32167 | 2 |
| FQ1 2026 (Feb 2026) | 1.07 | -55.14 | 1.04915 | 1.09085 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Nov 2026) | 0.72B | -- | 0.66B | 0.78B | 1 |
| FQ3 2026 (Aug 2026) | 0.98B | 22.59 | 0.97B | 0.99B | 1 |
| FQ2 2026 (May 2026) | 0.98B | 14.3 | 0.97B | 1B | 1 |
| FQ1 2026 (Feb 2026) | 0.88B | 13.14 | 0.86B | 0.89B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
4
Revenue # of Misses
2
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.15 | 1.18 | 0.03 | 2.54% |
| FQ3 2025 (Aug 2025) | 1.19333 | 1.19 | -0.0033300000000001 | -0.28% |
| FQ2 2025 (May 2025) | 1.92 | 1.92 | 100% | |
| FQ1 2025 (Feb 2025) | 1.66 | 1.66 | 100% | |
| FQ4 2024 (Nov 2024) | 3.9 | 3.9 | 100% | |
| FQ3 2024 (Aug 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (May 2024) | 1.09 | 1.09 | 100% | |
| FQ1 2024 (Feb 2024) | 1.07 | 1.07 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0.81B | $0B | $-809.43M | -INF% |
| FQ3 2025 (Aug 2025) | $0.94B | $0.76B | $-184.05M | -24.35% |
| FQ2 2025 (May 2025) | $0B | $0.84B | $842.7M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.76B | $762.1M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Aug 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (May 2024) | $0B | $0.82B | $818.7M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $0.86B | $861M | 100% |